Cargando…
Plasmepsin-like Aspartyl Proteases in Babesia
Apicomplexan genomes encode multiple pepsin-family aspartyl proteases (APs) that phylogenetically cluster to six independent clades (A to F). Such diversification has been powered by the function-driven evolution of the ancestral apicomplexan AP gene and is associated with the adaptation of various...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8540915/ https://www.ncbi.nlm.nih.gov/pubmed/34684190 http://dx.doi.org/10.3390/pathogens10101241 |
_version_ | 1784589102447853568 |
---|---|
author | Šnebergerová, Pavla Bartošová-Sojková, Pavla Jalovecká, Marie Sojka, Daniel |
author_facet | Šnebergerová, Pavla Bartošová-Sojková, Pavla Jalovecká, Marie Sojka, Daniel |
author_sort | Šnebergerová, Pavla |
collection | PubMed |
description | Apicomplexan genomes encode multiple pepsin-family aspartyl proteases (APs) that phylogenetically cluster to six independent clades (A to F). Such diversification has been powered by the function-driven evolution of the ancestral apicomplexan AP gene and is associated with the adaptation of various apicomplexan species to different strategies of host infection and transmission through various invertebrate vectors. To estimate the potential roles of Babesia APs, we performed qRT-PCR-based expressional profiling of Babesia microti APs (BmASP2, 3, 5, 6), which revealed the dynamically changing mRNA levels and indicated the specific roles of individual BmASP isoenzymes throughout the life cycle of this parasite. To expand on the current knowledge on piroplasmid APs, we searched the EuPathDB and NCBI GenBank databases to identify and phylogenetically analyse the complete sets of APs encoded by the genomes of selected Babesia and Theileria species. Our results clearly determine the potential roles of identified APs by their phylogenetic relation to their homologues of known function—Plasmodium falciparum plasmepsins (PfPM I–X) and Toxoplasma gondii aspartyl proteases (TgASP1–7). Due to the analogies with plasmodial plasmepsins, piroplasmid APs represent valuable enzymatic targets that are druggable by small molecule inhibitors—candidate molecules for the yet-missing specific therapy for babesiosis. |
format | Online Article Text |
id | pubmed-8540915 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-85409152021-10-24 Plasmepsin-like Aspartyl Proteases in Babesia Šnebergerová, Pavla Bartošová-Sojková, Pavla Jalovecká, Marie Sojka, Daniel Pathogens Article Apicomplexan genomes encode multiple pepsin-family aspartyl proteases (APs) that phylogenetically cluster to six independent clades (A to F). Such diversification has been powered by the function-driven evolution of the ancestral apicomplexan AP gene and is associated with the adaptation of various apicomplexan species to different strategies of host infection and transmission through various invertebrate vectors. To estimate the potential roles of Babesia APs, we performed qRT-PCR-based expressional profiling of Babesia microti APs (BmASP2, 3, 5, 6), which revealed the dynamically changing mRNA levels and indicated the specific roles of individual BmASP isoenzymes throughout the life cycle of this parasite. To expand on the current knowledge on piroplasmid APs, we searched the EuPathDB and NCBI GenBank databases to identify and phylogenetically analyse the complete sets of APs encoded by the genomes of selected Babesia and Theileria species. Our results clearly determine the potential roles of identified APs by their phylogenetic relation to their homologues of known function—Plasmodium falciparum plasmepsins (PfPM I–X) and Toxoplasma gondii aspartyl proteases (TgASP1–7). Due to the analogies with plasmodial plasmepsins, piroplasmid APs represent valuable enzymatic targets that are druggable by small molecule inhibitors—candidate molecules for the yet-missing specific therapy for babesiosis. MDPI 2021-09-26 /pmc/articles/PMC8540915/ /pubmed/34684190 http://dx.doi.org/10.3390/pathogens10101241 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Šnebergerová, Pavla Bartošová-Sojková, Pavla Jalovecká, Marie Sojka, Daniel Plasmepsin-like Aspartyl Proteases in Babesia |
title | Plasmepsin-like Aspartyl Proteases in Babesia |
title_full | Plasmepsin-like Aspartyl Proteases in Babesia |
title_fullStr | Plasmepsin-like Aspartyl Proteases in Babesia |
title_full_unstemmed | Plasmepsin-like Aspartyl Proteases in Babesia |
title_short | Plasmepsin-like Aspartyl Proteases in Babesia |
title_sort | plasmepsin-like aspartyl proteases in babesia |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8540915/ https://www.ncbi.nlm.nih.gov/pubmed/34684190 http://dx.doi.org/10.3390/pathogens10101241 |
work_keys_str_mv | AT snebergerovapavla plasmepsinlikeaspartylproteasesinbabesia AT bartosovasojkovapavla plasmepsinlikeaspartylproteasesinbabesia AT jaloveckamarie plasmepsinlikeaspartylproteasesinbabesia AT sojkadaniel plasmepsinlikeaspartylproteasesinbabesia |